Ovarian_Cancer_Action

Ovarian Cancer Action

Ovarian Cancer Action

Add article description

Ovarian Cancer Action is a charity based in the United Kingdom that funds scientific research both nationally and internationally. Nationally, the organisation funds the Ovarian Cancer Action Research Centre, based in the Institute of Reproductive and Developmental Biology (IRDB) on the Hammersmith Campus, and is one of the largest clusters of ovarian cancer research in Europe.[1][2] International funding is made available through competitive research funding calls.

The charity also promotes public awareness of ovarian cancer.[3] [4][5] On 8 May 2019 the charity carried out a symptoms awareness campaign for World Ovarian Cancer Day, which saw volunteers distributing 33,000 white roses with symptoms tags attached in locations throughout the United Kingdom.[6] Cross-party MPs, including Theresa May and Jeremy Corbyn, also wore a white rose to PMQs to show their support for the campaign.[7]

The charity's headquarters are located in London. The Ovarian Cancer Action Research Centre is located at Hammersmith Hospital, London.[8] The organisation is funded through donations and fundraising events.[9]

History

John Harris established the Helene Harris Memorial Trust (HHMT) in 1985 in memory of his wife who died from ovarian cancer. In 2005 John and Helene’s daughter, Allyson Kaye, developed the HHMT Trust into a charity called Ovarian Cancer Action.

A year later in 2006, Ovarian Cancer Action funded the creation of the Ovarian Cancer Action Research Centre at Hammersmith Hospital.

In 2015 and 2016 the charity funded research[10][11] and carried out a survey about women's health.[12][13]

HHMT Conference

Every four years Ovarian Cancer Action hosts and funds the HMMT International Forum which brings together international ovarian cancer scientists and clinicians to present recent advances and discuss future directions in ovarian cancer.

In 2011 the 12th HMMT International Forum produced the paper, Rethinking Ovarian Cancer: Recommendations for Improving Outcomes, in the journal Nature Reviews Cancer.[14]

References

  1. [1]
    "About us". Imperial College London. Retrieved 2019-06-24.
  2. [2]
    National Academies of Sciences, Engineering, and Medicine; Institute of Medicine; Board on Health Care Services, Committee on the State of the Science in Ovarian Cancer Research (25 May 2016). Ovarian Cancers: Evolving Paradigms in Research and Care. National Academies Press. pp. 45–. ISBN 978-0-309-38046-1.{{cite book}}: CS1 maint: multiple names: authors list (link)
  3. [3]
    "Half of young women too shy to discuss sex with GPs". The Times (subscription) Aug 18, 2015
  4. [4]
    "Ovarian cancer survival 'held back by stocism and embarrassment'".
  5. [5]
    "Why we really need to talk about Cara Delevingne and the Lady Garden campaign". Catch News, 29 August 2016,
  6. [6]
    "World Ovarian Cancer Day 2019". Ovarian Cancer Action. Retrieved 2019-06-24.
  7. [7]
    "Cross-party MPs wear white roses to PMQs for World Ovarian Cancer day". Evening Standard. 2019-05-08. Retrieved 2019-06-24.
  8. [8]
    "New pump a 'game-changer' for cancer patients". Retrieved 2015-04-23.
  9. [9]
    "Heacham mother stages fundraising walk for Ovarian Cancer Action". Lynn News, 31 March 2015.
  10. [10]
    "Ovarian cancer test on horizon as scientists find earliest signs of disease". The Telegraph, Sarah Knapton, 28 July 2016
  11. [11]
    "Large ovarian cancer study reveals new clues on genetics of chemoresistance". Medical News Today. 29 May 2015 by Catharine Paddock
  12. [12]
    "Women need to ditch the excuses and make time to see their doctor - here's how". Telegraph, Radhika Sanghani 29 February 2016
  13. [13]
    "Large ovarian cancer study reveals new clues on genetics of chemoresistance". Medical News Today. 29 May 2015 by Catharine Paddock
  14. [14]
    Vaughan, S.; Coward, J. I.; Bast Jr., R. C.; Berchuck, A.; Berek, J. S.; Brenton, J. D.; Coukos, G.; Crum, C. C.; Drapkin, R.; Etemadmoghadam, D.; Friedlander, M.; Gabra, H.; Kaye, S. B.; Lord, C. J.; Lengyel, E.; Levine, D. A.; McNeish, I. A.; Menon, U.; Mills, G. B.; Nephew, K. P.; Oza, A. M.; Sood, A. K.; Stronach, E. A.; Walczak, H.; Bowtell, D. D.; Balkwill, F. R. (2011). "Rethinking Ovarian Cancer: Recommendations for Improving Outcomes". Nature Reviews. Cancer. 11 (10): 719–725. doi:10.1038/nrc3144. PMC 3380637. PMID 21941283.
Share this article:

This article uses material from the Wikipedia article Ovarian_Cancer_Action, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.